Respirics, Inc. Completes Series A Financing
10/19/2005 5:12:55 PM
RALEIGH, N.C.--(BUSINESS WIRE)--Sept. 27, 2005--Respirics Inc., a pulmonary drug delivery and development company with headquarters in Raleigh, North Carolina, announced today that it has closed its Series A round of financing, receiving funds from both new and existing investors in the company. The round included the participation of two Research Triangle area early-stage investment firms, Catalysta Ventures and Research Triangle Ventures.
comments powered by